Sino Begin Period Cash Flow from 2010 to 2025

688108 Stock   10.88  0.05  0.46%   
Sino Medical's Begin Period Cash Flow is increasing over the years with slightly volatile fluctuation. Overall, Begin Period Cash Flow is expected to go to about 345.8 M this year. Begin Period Cash Flow is the amount of cash Sino Medical Sciences has at the beginning of a financial reporting period. It serves as the starting point for calculating the period's cash flow from operations, investing, and financing activities. View All Fundamentals
 
Begin Period Cash Flow  
First Reported
2019-12-31
Previous Quarter
199.5 M
Current Value
233 M
Quarterly Volatility
131.3 M
 
Covid
Check Sino Medical financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Sino Medical's main balance sheet or income statement drivers, such as Interest Expense of 2.8 M, Selling General Administrative of 82.7 M or Total Revenue of 246.2 M, as well as many indicators such as . Sino financial statements analysis is a perfect complement when working with Sino Medical Valuation or Volatility modules.
  
This module can also supplement various Sino Medical Technical models . Check out the analysis of Sino Medical Correlation against competitors.

Currently Active Assets on Macroaxis

Other Information on Investing in Sino Stock

Sino Medical financial ratios help investors to determine whether Sino Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Sino with respect to the benefits of owning Sino Medical security.